$19.60
0.361.87%
At Close: -
$19.60
00.00%
After Hours: 4:03 PM EDT
15 minutes delayed
Healthpeak Properties
DOCNYSE
Healthpeak Properties (NYSE:DOC) Stock, Analyst Ratings, Price Targets, Predictions
Healthpeak Properties Inc has a consensus price target of $15.19, established from looking at the 40 latest analyst ratings. The last 3 analyst ratings were released from Scotiabank, JP Morgan, and Mizuho on May 16, 2024, May 16, 2024, and April 22, 2024. With an average price target of $22 between Scotiabank, JP Morgan, and Mizuho, there's an implied 12.24% upside for Healthpeak Properties Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Scotiabank
JP Morgan
Wedbush
Mizuho
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Healthpeak Properties
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | 17.35% | Scotiabank | Nicholas Yulico | $22 → $23 | Maintains | Sector Outperform | Get Alert |
| 05/16/2024 | Buy Now | 7.14% | JP Morgan | Michael Mueller | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | Wedbush | Richard Anderson | — | Upgrade | Neutral → Outperform | Get Alert |
| 04/22/2024 | Buy Now | 12.24% | Mizuho | Vikram Malhotra | → $22 | Reinstates | → Buy | Get Alert |
| 04/10/2024 | Buy Now | 12.24% | RBC Capital | Michael Carroll | $21 → $22 | Maintains | Outperform | Get Alert |
| 04/01/2024 | Buy Now | 27.55% | B of A Securities | Joshua Dennerlein | $18 → $25 | Upgrade | Underperform → Buy | Get Alert |
| 03/25/2024 | Buy Now | -3.06% | Wells Fargo | Connor Siversky | → $19 | Reinstates | → Equal-Weight | Get Alert |
| 03/08/2024 | Buy Now | 7.14% | RBC Capital | Michael Carroll | → $21 | Reinstates | → Outperform | Get Alert |
| 01/05/2024 | Buy Now | — | Keybanc | Todd Thomas | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 01/02/2024 | Buy Now | -8.16% | Compass Point | Merrill Ross | $19 → $18 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | -28.57% | Truist Securities | Michael Lewis | $15 → $14 | Maintains | Hold | Get Alert |
| 08/22/2023 | Buy Now | -28.57% | Citigroup | Michael Bilerman | $15 → $14 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -23.47% | Truist Securities | Michael Lewis | → $15 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | -23.47% | Wells Fargo | Connor Siversky | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | -26.02% | Morgan Stanley | Richard Hill | $14.5 → $14.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/26/2023 | Buy Now | -20.92% | JMP Securities | Aaron Hecht | → $15.5 | Initiates | → Market Outperform | Get Alert |
| 04/20/2023 | Buy Now | -28.57% | Wells Fargo | Connor Siversky | → $14 | Initiates | → Underweight | Get Alert |
| 04/19/2023 | Buy Now | -28.57% | Wells Fargo | Connor Siversky | → $14 | Initiates | → Underweight | Get Alert |
| 03/29/2023 | Buy Now | -23.47% | Credit Suisse | Omotayo Okusanya | → $15 | Reiterates | → Neutral | Get Alert |
| 03/27/2023 | Buy Now | -3.06% | Compass Point | Floris Van Dijkum | $21 → $19 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | -23.47% | RBC Capital | Michael Carroll | $16 → $15 | Maintains | Sector Perform | Get Alert |
| 01/17/2023 | Buy Now | -8.16% | Barclays | Steve Valiquette | $20 → $18 | Maintains | Overweight | Get Alert |
| 12/14/2022 | Buy Now | -13.27% | Keybanc | Todd Thomas | → $17 | Upgrade | Sector Weight → Overweight | Get Alert |
| 11/01/2022 | Buy Now | -26.02% | Morgan Stanley | Richard Hill | $16.5 → $14.5 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | -13.27% | JP Morgan | Michael Mueller | → $17 | Initiates | → Neutral | Get Alert |
| 08/31/2022 | Buy Now | -15.82% | Morgan Stanley | Richard Hill | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | Buy Now | -18.37% | Morgan Stanley | Richard Hill | $17.5 → $16 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | -13.27% | Truist Securities | Michael Lewis | $18 → $17 | Maintains | Hold | Get Alert |
| 06/30/2022 | Buy Now | 2.04% | Jefferies | Jonathan Petersen | $21 → $20 | Maintains | Buy | Get Alert |
| 06/01/2022 | Buy Now | -10.71% | Morgan Stanley | Richard Hill | $18 → $17.5 | Maintains | Equal-Weight | Get Alert |
| 05/20/2022 | Buy Now | -3.06% | RBC Capital | Michael Carroll | $18 → $19 | Maintains | Sector Perform | Get Alert |
| 05/19/2022 | Buy Now | -8.16% | B of A Securities | Joshua Dennerlein | → $18 | Downgrade | Neutral → Underperform | Get Alert |
| 04/26/2022 | Buy Now | 2.04% | Barclays | Steve Valiquette | → $20 | Initiates | → Overweight | Get Alert |
| 03/09/2022 | Buy Now | -8.16% | RBC Capital | Michael Carroll | $19 → $18 | Maintains | Sector Perform | Get Alert |
| 03/07/2022 | Buy Now | -8.16% | Morgan Stanley | Richard Hill | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | Buy Now | -3.06% | Credit Suisse | Tayo Okusanya | → $19 | Initiates | → Neutral | Get Alert |
| 01/07/2022 | Buy Now | 2.04% | BMO Capital | John Kim | → $20 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/29/2021 | Buy Now | -3.06% | Morgan Stanley | Richard Hill | — | Maintains | Equal-Weight | Get Alert |
| 09/13/2021 | Buy Now | — | Morgan Stanley | Vikram Malhorta | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/20/2021 | Buy Now | — | Raymond James | Jonathan Hughes | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Healthpeak Properties (DOC) stock?
The latest price target for Healthpeak Properties (NYSE:DOC) was reported by Scotiabank on May 16, 2024. The analyst firm set a price target for $23.00 expecting DOC to rise to within 12 months (a possible 17.35% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthpeak Properties (DOC)?
The latest analyst rating for Healthpeak Properties (NYSE:DOC) was provided by Scotiabank, and Healthpeak Properties maintained their sector outperform rating.
When was the last upgrade for Healthpeak Properties (DOC)?
The last upgrade for Healthpeak Properties Inc happened on May 3, 2024 when Wedbush raised their price target to N/A. Wedbush previously had a neutral for Healthpeak Properties Inc.
When was the last downgrade for Healthpeak Properties (DOC)?
The last downgrade for Healthpeak Properties Inc happened on January 5, 2024 when Keybanc changed their price target from N/A to N/A for Healthpeak Properties Inc.
When is the next analyst rating going to be posted or updated for Healthpeak Properties (DOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthpeak Properties, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthpeak Properties was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating Healthpeak Properties (DOC) correct?
While ratings are subjective and will change, the latest Healthpeak Properties (DOC) rating was a maintained with a price target of $22.00 to $23.00. The current price Healthpeak Properties (DOC) is trading at is $19.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.